共 50 条
- [11] DOSIMETRIC CHARACTERISTICS, AIR-KERMA STRENGTH CALIBRATION AND VERIFICATION OF MONTE-CARLO SIMULATION FOR A NEW YB-169 BRACHYTHERAPY SOURCE INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (04): : 953 - 970
- [13] MISONIDAZOLE COMBINED WITH LARGE-FRACTION PELVIC IRRADIATION IN THE TREATMENT OF PATIENTS WITH ADVANCED PELVIC MALIGNANCIES - PRELIMINARY-REPORT OF AN ONGOING RTOG PHASE I-II STUDY AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (04): : 417 - 422
- [15] INFUSIONAL BRACHYTHERAPY IN THE TREATMENT OF NONRESECTABLE PANCREATIC-CANCER - A NEW RADIATION MODALITY (PRELIMINARY-REPORT OF THE PHASE-I STUDY) ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS, 1994, 7 (01): : 11 - 27
- [16] PHASE-I-II CLINICAL STUDIES WITH IV AND ORAL FTORAFUR, A PRELIMINARY-REPORT PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 349 - 349
- [17] Technical Note: Monte Carlo calculations of the AAPM TG-43 brachytherapy dosimetry parameters for a new titanium-encapsulated Yb-169 source JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2017, 18 (04): : 193 - 199
- [19] Phase I/II study on kilovoltage surface brachytherapy in conjunctival cancer: preliminary results ECANCERMEDICALSCIENCE, 2018, 12
- [20] RADIOFREQUENCY HYPERTHERMIA IN MALIGNANCY - A PHASE I-II STUDY PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 158 - 158